anayamalik, Author at European Medical Journal - Page 48 of 83

Tolebrutinib Targets Chronic Lesions in MS Treatment: ACTRIMS 2025

A new analysis of Phase III clinical trial data presented at the ACTRIMS Forum 2025 in West Palm Beach, Florida, suggests that tolebrutinib, a Bruton’s tyrosine kinase inhibitor (BTKi), may be effective in multiple sclerosis (MS) with chronic active lesions.

How Can We Manage Insomnia in Obstructive Sleep Apnea?

Researchers found that insomnia symptoms significantly contribute to patient-reported excessive daytime sleepiness (EDS) in a recent study examining obstructive sleep apnea (OSA).

Prostate Cancer Initiative Boosts Screening Among Black Men in Michigan

In Southeastern Michigan, Black men face disproportionately higher mortality rates from prostate cancer, often presenting with more advanced disease stages.

Norovirus Outbreaks Predicted Using Internet Search Trends

Norovirus outbreaks may soon be easier to detect thanks to a novel approach combining Google search trends and wastewater surveillance.

Elevated Melanoma Risk in Childhood Cancer Survivors

A recent study has revealed that adult survivors of childhood cancer face a significantly elevated risk of developing melanoma, underscoring the necessity for vigilant long-term monitoring and tailored preventive strategies.

Alarming Rise in US Female Physician Suicides

A troubling trend showing female physicians in the United States are dying by suicide at significantly higher rates than their counterparts in the general population has been exposed in a recent cohort study.

Lung Cancer Screening: Comorbidity and Diversity Challenges Revealed

A recent cohort study has highlighted significant disparities in comorbidity profiles among patients undergoing low-dose computed tomography (LDCT) for lung cancer screening.

Menthol Cigarettes Carry Higher Mortality Risk Compared to Non-Menthol

Smoking menthol-flavored cigarettes is associated with higher mortality risks compared to non-menthol cigarettes according to a new study.

Managing PTLD in Pediatric Liver Transplants

The significant concern of Epstein-Barr virus (EBV) in pediatric liver transplant recipients due to its strong association with post-transplant lymphoproliferative disorder (PTLD) has been explored in a recently published study.

RA Drugs Show Promise Despite Kidney Issues

Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.